| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice
|
Wikstrom, Matthew E.
|
|
|
126 |
12 |
p. 1503-1514
|
article
|
| 2 |
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
|
Donadieu, Jean
|
|
|
126 |
12 |
p. 1415-1423
|
article
|
| 3 |
Cystine crystals in bone marrow aspirate
|
Monier, Laurie
|
|
|
126 |
12 |
p. 1515
|
article
|
| 4 |
Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation
|
Konstantinidis, Diamantis G.
|
|
|
126 |
12 |
p. 1473-1482
|
article
|
| 5 |
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing
|
Leone, Patrizia
|
|
|
126 |
12 |
p. 1443-1451
|
article
|
| 6 |
Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation
|
Sperlazza, Justin
|
|
|
126 |
12 |
p. 1462-1472
|
article
|
| 7 |
Diagnosis of hantavirus cardiopulmonary syndrome with peripheral blood film
|
Prokopchuk-Gauk, Oksana
|
|
|
126 |
12 |
p. 1516
|
article
|
| 8 |
Does GVHD make amateurs out of professional APCs?
|
Hanash, Alan M.
|
|
|
126 |
12 |
p. 1404-1405
|
article
|
| 9 |
Editorial Board
|
|
|
|
126 |
12 |
p. i
|
article
|
| 10 |
FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow
|
Zhu, Shu
|
|
|
126 |
12 |
p. 1494-1502
|
article
|
| 11 |
Myeloma escape from immunity: an “inside” job
|
Rapoport, Aaron P.
|
|
|
126 |
12 |
p. 1401-1403
|
article
|
| 12 |
Nasal NK/T-cell lymphoma: RT, CT, or both
|
Tse, Eric
|
|
|
126 |
12 |
p. 1400-1401
|
article
|
| 13 |
Platelets induce apoptosis via membrane-bound FasL
|
Schleicher, Rebecca I.
|
|
|
126 |
12 |
p. 1483-1493
|
article
|
| 14 |
Polyphosphates rock! A role in thrombosis?
|
Monroe, Dougald M.
|
|
|
126 |
12 |
p. 1403-1404
|
article
|
| 15 |
Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy
|
Zohren, Fabian
|
|
|
126 |
12 |
p. 1407-1414
|
article
|
| 16 |
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study
|
Yang, Yong
|
|
|
126 |
12 |
p. 1424-1432
|
article
|
| 17 |
Risk-adapted therapy for extranodal NKTCL
|
|
|
|
126 |
12 |
p. 1517
|
article
|
| 18 |
Risk organ + LCH gets the one-two punch?
|
Stine, Kimo C.
|
|
|
126 |
12 |
p. 1399-1400
|
article
|
| 19 |
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
|
Rook, Alain H.
|
|
|
126 |
12 |
p. 1452-1461
|
article
|
| 20 |
Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy
|
Zhou, Xiaoxi
|
|
|
126 |
12 |
p. 1433-1442
|
article
|
Journal description